N-ras Mutations in Acute Myelogenous Leukemia: A Review of the Current Literature and an update of the Southwest Oncology Group Experience

References

• Toksoz D., Farr C. J., Marshall C. J. Ras genes and acute myeloid leukemia. Brit. J. Haematol. 1989; 71: 1–6
   PubMed Web of Science ®Google Scholar
• Bos J. L. Ras oncogenes in human cancer: a review. Cancer Res. 1989; 49: 4682–4689
   PubMed Web of Science ®Google Scholar
• Bourne H. R., Sanders D. A., McCormick F. The GTPase superfamily: conserved structure and molecular mechanism. Nature 1991; 349: 117–127
   PubMed Web of Science ®Google Scholar
• McCormick F. Ras GTPase activating protein: signal transmitter and signal terminator. Cell 1989; 56: 5–8
   PubMed Web of Science ®Google Scholar
• Trahey M., McCormick F. A cytoplasmic protein stimulates N-ras p21 GTPase, but does not affect oncogenic mutants. Science 1987; 238: 542–54
   PubMed Web of Science ®Google Scholar
• Varmus H. The molecular genetics of cellular oncogenes. Ann. Rev. Genet. 1984; 18: 560–612
   Google Scholar
• Bos J., Toksoz D., Marshall C., Verlaan-de Vries M., Veeneman G. H., van der Eb A. J., van Boom J. H., Janssen J. W. G., Steenvorden A. C. M. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature 1985; 315: 726–730
   PubMed Web of Science ®Google Scholar
• Needleman S., Kraus M., Srivastava S., Levine P., Aaronson S. High frequency of N-ras activation in acute myelogenous leukemia. Blood 1986; 67: 753–757
   PubMed Web of Science ®Google Scholar
• Bos J., Verlaan-de Vries M., van der Eb A. J., Janssen J. W. G., Delwel R., Lwenberg B., Colly L. P. Mutations in N-ras predominate in acute myeloid leukemia. Blood 1987; 69: 1237–1241
   PubMed Web of Science ®Google Scholar
• Toksoz D., Farr C. J., Marshall C. J. Ras gene activation in a minor proportion of the blast cell population in acute myeloid leukemia. Oncogene 1987; 1: 409–413
   PubMed Web of Science ®Google Scholar
• Janssen J. W. G., Steenvoorden A. C. M., Lyons J., Anger B., Bhlke J. U., Bos J. L., Seliger H., Bartram C. R. Ras gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc. Natl. Sci. USA 1987; 84: 9228–9232
   PubMed Web of Science ®Google Scholar
• Senn H. P., Tran-Thang C., Wodnar-Filipowicz A., Jiricny J. H., Fopp M., Gratwohl A., Signer E., Wever W., Moroni C. Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias. Int. J. Cancer 1988; 41: 59–64
   PubMed Web of Science ®Google Scholar
• Farr C. J., Saiki R. K., Erlich H. A., McCormick F., Marshall C. J. Analysis of Ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc. Natl, Acad, Sci. USA 1988; 1629–1633
   PubMed Web of Science ®Google Scholar
• Browett P. J., Norton J. D. Analysis of ras gene mutations and methylation state in human leukemia. Oncogene 1989; 4: 1029–1036
   PubMed Web of Science ®Google Scholar
• Bartram C. R., Ludwig W.-D., Hiddemann W., Lyons J., Buschle M., Ritter J., Harbott J., Frohlich A., Janssen J. W. G. Acute myeloid leukemia: Analysis of Ras gene mutations and clonality denned by polymorphic-linked loci. Leukemia 1989; 3: 247–256
   PubMed Web of Science ®Google Scholar
• Yunis J. J., Boot A. J. M., Mayer M. G., Bos J. L. Mechanisms of ras mutation in myelodysplastic syndrome. Oncogene 1990; 4: 609–614
   Web of Science ®Google Scholar
• Ahuja H. G., Foti A., Bar-Eli M., Cline M. J. The pattern of mutational involvement of Ras genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75: 1684–1690
   PubMed Web of Science ®Google Scholar
• Radich J. P., Kopecky K. J., Willman C. L., Weick J., Head D., Appelbaum F., Collins S. J. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Blood 1990; 16: 801–807
   Google Scholar
• Mane S. M., Meltzer S. J., Gutheil J. C., Kapil V., Lee E. J., Needleman S. W. Ras gene activation in acute myelogenous leukemia: analysis of in vitro amplification and DNA base sequence determination. Genes, Chromo., and Cane. 1990; 2: 71–77
   PubMed Web of Science ®Google Scholar
• Vogelstein B., Civin C. I., Preisinger A. C., Krischer J. P., Steuber P., Ravindranath Y., Weinstein H., Elfferich P., Bos J. Ras gene mutations in childhood acute myeloid leukemia: a pediatric oncology group study. Genes, Chromo., and Cane. 1990; 2: 149–162
   Google Scholar
• Farr C., Gill R., Katz F., Gibbons B., Marshall C. J. Analysis of ras gene mutations in childhood myeloid leukaemia. Brit. J. Haematol. 1991; 11: 323–327
   Web of Science ®Google Scholar
• MacDonald R. J., Swift G. H., Przybyla A. E., Chrigwin J. J. Isolation of RNA using guanidinium salts. Methods Enzymol. 1987; 15: 219–226
   Google Scholar
• Saiki P. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., Mullis K. B., Erlich H. A. Primer-directed enzymatic amplification of DNA with thermostable DNA polymerase. Science 1988; 239: 487–491
   PubMed Web of Science ®Google Scholar
• Collins S. J. Direct sequencing of amplified genomic fragments documents N-ras point mutations in myeloid leukemia. Oncogene Res. 1988; 3: 117–124
   PubMedGoogle Scholar
• Winship P. R. An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucl. Acids Res. 1989; 17: 126
   Web of Science ®Google Scholar
• Lehmann E. L. Nonparametries: Statistical Methods Based on Ranks. Holden-Day, Inc., San Francisco 1975
   Google Scholar
• Cox D. R. Analysis of Binary Data. Chapman and Hall, London 1970
   Google Scholar
• Kalbfleisch J. D., Prentice R. L. The Statistical Analysis of Failure Time Data. John Wiley and Sons, New York 1980
   Google Scholar
• Kaplan E. L., Meier P. Nonparametric estimation from incomplete observations. J. Amer. Stat. Assoc. 1958; 53: 457–481
   Web of Science ®Google Scholar
• Rovera G., Reichard B. A., Hudson S., Bittenbender S., Yamada M., Tournay O., Preisler H. D. Point mutations in both transforming and non-transforming codons of the N-ras proto-oncogene of Ph + leukemias. Oncogene 1989; 4: 867–872
   PubMed Web of Science ®Google Scholar
• Gambke C., Signer E., Moroni C. Activation of N-ras gene in bone marrow cells from a patient with acute myeloblasts leukaemia. Nature 1984; 307: 476–428
   PubMed Web of Science ®Google Scholar
• Knapp R. H., Dewald G. W., Pierre R. V. Cytogenetic studies in 174 consecutive patients with pre-leukemic or myelodysplastic syndromes. Mayo Clin. Proc. 1985; 60: 507–516
   PubMed Web of Science ®Google Scholar
• Sokal G., Michaux J. L., Van Den Berghe H., Cordier A., Rodhain J., Ferrant A., Moriau M., De Bruyere M., Sonnet J. A new hematologic syndrome with a distinct karyotype. The 5q- chromosome. Blood 1975; 46: 519–533
   PubMed Web of Science ®Google Scholar
• Padua R. A., Carter G., Hughes D., Gow J., Farr C., Oscier D., McCormick F., Jacobs A. Ras mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia 1988; 2: 503–510
   PubMed Web of Science ®Google Scholar
• Bar-Eli M., Ahuja H., Gonzalz-Cadavid N., Foti A., Cline M. J. Analysis of N-ras exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing. Blood 1989; 13: 281–283
   Google Scholar
• Jacobs A. Genetic lesions in preleukemia. Leukemia 1991; 5: 277–282
   PubMed Web of Science ®Google Scholar
• Toorchen D., Topal M. D. Mechanisms of chemical mutagenesis and carcinogenesis: effects on DNA replication of methylation at the O6 guanine position of dGTP. Carcinogenesis 1983; 4: 1591–1597
   PubMed Web of Science ®Google Scholar
• Zarbl H., Sukumar S., Arthur A. J., Martin-Zanca D., Barbacid M. Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 1985; 315: 382–385
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J., Janssen J. W. G., Lyons J., Philip P., Bartram C. R. Point mutations of the ras proto-oncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agents. Cane. Res. 1988; 48: 1812–1817
   PubMed Web of Science ®Google Scholar
• Fourth International Workshop on Chromosomes in Leukemia. Cancer Genet. Cytogenet. 1984; 11: 249–360
   PubMed Web of Science ®Google Scholar
• Lübbert M., Mirro J., Jr, Miller C. W., Kahan J., Isaac G., Kitchingman G., Mertelsmann R., Herrmann F., McCormick F., Koeffler H. P. N-ras gene point mutations in childhood acute lymphocyte leukemia correlate with a poor prognosis. Blood 1990; 75: 1163–1169
   PubMed Web of Science ®Google Scholar
• Shen W. P. V., Aldrich T. H., Venta-Perez G., Franza B. R., Furth M. E. Expression of normal and mutant ras proteins in human acute leukemia. Oncogene 1987; 1: 157–165
   PubMed Web of Science ®Google Scholar
• Senn H. P., Jiricny J., Fopp M., Schmid L., Moroni C. Relapse cell population differs from acute onset clone as shown by absence of the initially activated N-ras oncogene in a patient with acute monocytic leukemia. Blood 1988; 72: 931–935
   PubMed Web of Science ®Google Scholar
• Kirai H., Kobayashi Y., Mano H., Hagiwara K., Maru Y., Omine M., Mizoguchi H., Nishida J., Takaku F. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 1987; 327: 430–432
   PubMed Web of Science ®Google Scholar
• Lyons J., Janssen J. W. G., Bartram C., Layton M., Mufti G. H. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. Blood 1988; 71: 1707–1712
   PubMed Web of Science ®Google Scholar
• Melani C., Haliassos A., Chomel J. C., Miglino M., Ferraris A. M., Gaetani G. F., Kaplan J. C., Kitzis A. Ras activation in myelodysplastic syndromes: clinical and molecular study of the chronic phase of the disease. Brit. J. Haematol. 1990; 74: 408–413
   PubMed Web of Science ®Google Scholar
• Nakagawa T., Saitoh S., Imoto S., Itoh M., Tsutsumi M., Hikiji K., Nakao Y., Fujita T. Loss of multiple point mutation of Ras genes associated with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome. Br. J. Haematol. 1991; 77: 250–252
   PubMed Web of Science ®Google Scholar
• Martin G. A., Viskochil D., Bollag G., McCabe P. C., Crosier W. J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R. M., Innis M. A., McCormick F. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990; 63: 843–849
   PubMed Web of Science ®Google Scholar
• Gangfeng X., O'Connell P., Viskochil D., Cawthorn R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R., Weiss R. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62: 599–608
   PubMed Web of Science ®Google Scholar
• Vollag G., McCormick F. Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature 1991; 351: 576–579
   PubMed Web of Science ®Google Scholar